Second primary lung cancer after a first breast cancer : a case report and critical literature review
暂无分享,去创建一个
Jinhua Luo | Wang | Heng Wang | Fengwei Kong | Wenbin Wu | Miao Zhang | Hui Zhang | Tian Zhao | Chun-ying
[1] Y. Rycke,et al. Risks of second malignancies after breast cancer treatment: Long-term results. , 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[2] D. Mankoff,et al. Molecular Imaging and Precision Medicine in Breast Cancer. , 2017, PET clinics.
[3] J. Overgaard,et al. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] L. Marcu,et al. Risk estimation of second primary cancers after breast radiotherapy , 2016, Acta oncologica.
[5] Tatiana Martins Tilli,et al. Toward precision medicine of breast cancer , 2016, Theoretical Biology and Medical Modelling.
[6] Elizabeth S. McDonald,et al. Clinical Diagnosis and Management of Breast Cancer , 2016, The Journal of Nuclear Medicine.
[7] S. Loi,et al. Precision medicine for metastatic breast cancer—limitations and solutions , 2015, Nature Reviews Clinical Oncology.
[8] S. Ou,et al. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review. , 2015, Clinical lung cancer.
[9] J. Agarwal,et al. A rare case of multicentric carcinoma left breast synchronous with carcinoma right lung: Therapeutic challenge in radiotherapy. , 2015, Journal of Cancer Research and Therapeutics.
[10] Mei Jin,et al. Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report. , 2015, International journal of clinical and experimental pathology.
[11] Xuanwei Wang,et al. Perineural invasion: a potential reason of hepatocellular carcinoma bone metastasis. , 2015, International journal of clinical and experimental medicine.
[12] W. Liang,et al. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis. , 2015, Lung cancer.
[13] C. Vecchia,et al. Second primary cancers in the Vaud and Neuchâtel Cancer Registries , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[14] Chia-Chuan Liu,et al. Second primary lung cancers among breast cancer patients treated with anti-estrogens have a longer cancer-specific survival. , 2015, Anticancer research.
[15] J. Overgaard,et al. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Yoko Yamamoto,et al. [Occurrence of squamous cell lung carcinoma in the irradiated field after radiotherapy for breast cancer]. , 2014, Gan to kagaku ryoho. Cancer & chemotherapy.
[17] R. Strawderman,et al. Non–Small-Cell Lung Cancer After Breast Cancer: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes in 3529 Women , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] M. S. Thomsen,et al. Risk of second primary lung cancer in women after radiotherapy for breast cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] N. Reinmuth,et al. Characteristics of lung cancer after a previous malignancy. , 2014, Respiratory medicine.
[20] J. Shrager. Approach to the patient with multiple lung nodules. , 2013, Thoracic surgery clinics.
[21] P. Lara,et al. Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy. , 2012, Surgical oncology.
[22] A. Berrington de González,et al. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status , 2012, Cancer Causes & Control.